I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH ...

View the latest Equifax Inc. (EFX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...

Shares of Equifax Inc. EFX slid 2.06% to $248.07 Thursday, on what proved to be an all-around mixed trading session for the ...

View and compare FIG,BMRN,HOOD,CRWV,NVDA,NVDX,AMD,URA,NUKZ,AMZN,AMZU,MSFT,GOOG,RTX,EFX,JAZZ on Yahoo Finance.

A number of stocks jumped in the afternoon session after markets continued to rally as investor optimism grew for a potential ...

近日，洛杉矶湖人队记Buha预测了新赛季球队10人轮换。 相比于斯马特顶替八村塁打首发，我更意外的是克内克特跌出轮换阵容。多说一句，24-25赛季克内克特合计出场1494分钟，队内第5。 克内克特失宠的原因是什么？ 我认为有两点： ...